Volume 12, Number 3—March 2006
Letter
Rickettsia slovaca Infection, France
Frédérique Gouriet*, Jean-Marc Rolain*, and Didier Raoult*
Table A1
Laboratory results for 14 patients with Rickettsia slovaca infection*
| Patient | MIF assay |
Culture |
PCR |
||||||
|---|---|---|---|---|---|---|---|---|---|
| Acute-phase serum† | Convalescent-phase serum* | WB | Cross-adsorption | Skin biopsy | Tick | Skin biopsy | Tick | Acute phase serum | |
| 1 | 256/0 | 256/0 | + | R. slovaca | – | NA | – | NA | – |
| 2 | 0/32 | NA | + | R. slovaca | – | NA | R. slovaca | NA | – |
| 3 | 0/0 | 0/0 | + | R. slovaca | R. slovaca | NA | R. slovaca | NA | – |
| 4 | 0/0 | 0/0 | NA | NA | R. slovaca | NA | R. slovaca | NA | – |
| 5 | 0/0 | 32/32 | + | R. slovaca | NA | NA | NA | NA | R. slovaca |
| 6 | 0/32 | 0/32 | + | R. slovaca | NA | NA | NA | NA | – |
| 7 | 0/0 | 64/64 | NA | NA | NA | R. slovaca | NA | R. slovaca | – |
| 8 | 0/0 | NA | + | R. slovaca | – | NA | – | NA | – |
| 9 | 32/32 | NA | + | R. slovaca | – | NA | – | NA | – |
| 10 | 0/0 | NA | NA | NA | NA | NA | NA | R. slovaca | – |
| 11 | 0/0 | NA | NA | NA | NA | NA | NA | NA | – |
| 12 | 64/0 | 64/0 | + | R. slovaca | – | – | – | R. slovaca | – |
| 13 | 0/128 | NA | + | R. slovaca | NA | NA | NA | NA | – |
| 14 | 256/128 | NA | + | R. slovaca | NA | NA | NA | NA | – |
*MIF, microimmunofluorescence; WB, Western blot; PCR, polymerase chain reaction; NA, not available.
†Antibody titers are immunoglobulin G (IgG)/IgM against R. slovaca.
Page created: January 27, 2012
Page updated: January 27, 2012
Page reviewed: January 27, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.